Massive study tracks 2,424 Women's cancer treatment journeys

NCT ID NCT04943497

Completed Knowledge-focused Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This observational study followed 2,424 Russian women with advanced breast cancer to understand how different treatments work in real-world settings. Researchers tracked patients already receiving standard medications like ribociclib, alpelisib, hormone therapy, or chemotherapy as part of their normal care. The goal was to collect information about treatment effectiveness, side effects, and quality of life without changing anyone's treatment plan.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Novartis Investigative Site

Syktyvkar, Komi, 167904, Russia
Novartis Investigative Site

Sochi, Russian Federation, 354057, Russia
Novartis Investigative Site

Kaluga, Russia, 248007, Russia
Novartis Investigative Site

Surgut, Tymen Area, 628402, Russia
Novartis Investigative Site

Arkhangelsk, 163045, Russia
Novartis Investigative Site

Barnaul, 656045, Russia
Novartis Investigative Site

Belgorod, 308010, Russia
Novartis Investigative Site

Bryansk, 241028, Russia
Novartis Investigative Site

Cheboksary, 428020, Russia
Novartis Investigative Site

Chelyabinsk, 454087, Russia
Novartis Investigative Site

Cherkessk, 369000, Russia
Novartis Investigative Site

Chita, 672027, Russia
Novartis Investigative Site

Irkutsk, 664035, Russia
Novartis Investigative Site

Ivanovo, 153040, Russia
Novartis Investigative Site

Izhevsk, 426009, Russia
Novartis Investigative Site

Kaliningrad, 236016, Russia
Novartis Investigative Site

Khabarovsk, 680042, Russia
Novartis Investigative Site

Khanty-Mansiysk, 628012, Russia
Novartis Investigative Site

Kirov, 610021, Russia
Novartis Investigative Site

Kostroma, 156005, Russia
Novartis Investigative Site

Krasnodar, 350040, Russia
Novartis Investigative Site

Krasnoyarsk, 660022, Russia
Novartis Investigative Site

Moscow, 105005, Russia
Novartis Investigative Site

Moscow, 111123, Russia
Novartis Investigative Site

Moscow, 115304, Russia
Novartis Investigative Site

Moscow, 115522, Russia
Novartis Investigative Site

Moscow, 129110, Russia
Novartis Investigative Site

Moscow, 143423, Russia
Novartis Investigative Site

Moscow Region Balas, 143900, Russia
Novartis Investigative Site

Nal'chik, 360051, Russia
Novartis Investigative Site

Nizhny Novgorod, 603081, Russia
Novartis Investigative Site

Novosibirsk, 630108, Russia
Novartis Investigative Site

Odintsovo, 143003, Russia
Novartis Investigative Site

Omsk, 644013, Russia
Novartis Investigative Site

Perm, 614066, Russia
Novartis Investigative Site

Podolsk, 142110, Russia
Novartis Investigative Site

Pyatigorsk, 357502, Russia
Novartis Investigative Site

Rostov-on-Don, 344006, Russia
Novartis Investigative Site

Saint Petersburg, 191104, Russia
Novartis Investigative Site

Saint Petersburg, 194214, Russia
Novartis Investigative Site

Saint Petersburg, 197758, Russia
Novartis Investigative Site

Saransk, 430032, Russia
Novartis Investigative Site

Saratov, 410053, Russia
Novartis Investigative Site

Sestroretsk, 197706, Russia
Novartis Investigative Site

Sevastopol’, 299045, Russia
Novartis Investigative Site

Severodvinsk, 450054, Russia
Novartis Investigative Site

Simferopol, 295023, Russia
Novartis Investigative Site

Tambov, 392000, Russia
Novartis Investigative Site

Tula, 300040, Russia
Novartis Investigative Site

Tver', 170008, Russia
Novartis Investigative Site

Tyumen, 625041, Russia
Novartis Investigative Site

Ufa, 450054, Russia
Novartis Investigative Site

Vladikavkaz, 362002, Russia
Novartis Investigative Site

Vladivostok, 690105, Russia
Novartis Investigative Site

Voronezh, 394036, Russia
Novartis Investigative Site

Yekaterinburg, 620027, Russia
Novartis Investigative Site

Yekaterinburg, 620036, Russia
Novartis Investigative Site

Yuzhno-Sakhalinsk, 693010, Russia

Conditions

Explore the condition pages connected to this study.

BREAST CANCER